The documents submitted to the CTN+ undergo peer review by the Scientific Review Committee (SRC), if required and not previously peer-reviewed, and the Community Advisory Committee (CAC). All committee members are bound by confidentiality agreements. Information about the review committees may be found in our Committees section.
- The CAC reviews all Full Submissions.
- The CTN+ will accept the review of other nationally recognized peer-review panels of clinical trials/research, such as CIHR’s or NIH’s randomized controlled trial (RCT) review panels. In such cases, a full review by the SRC is not necessary. All external reviews must be included in the submission.
- If approved, the submission will be forwarded to the CTN+ Steering Committee and Research Allocation Committee for CTN+ approval and provision of in-kind and assistance with sourcing the cost-recovery service in one of the CTN+ regions. Applicants will be provided with an award letter that outlines the in-kind and CTN+ Regional location of their cost-recovery services, feedback from the CTN+ Review Committee. In the award letter email, the applicant will also be provided with contact details for their Regional CTN+ Project Manager who will assist the applicant by scheduling the required Study Kick-Off meeting. All service providers for the approved study will attend this meeting.
- Successful applicants are required to provide the CTN+ with the enrolment updates, notification of conference presentations, and publications as outlined in the correspondence they receive from the CTN+.
- Applicants who suspend CTN+ approved projects for any reason are required to report this suspension immediately.
- Successful applicants are required to acknowledge CTN support when issuing publications, scientific presentations, press releases, and other documents describing projects or programs supported by the CTN in whole or in part. CTN Publication Guidelines are available online and are provided to successful applicants.
The CTN cannot grant final approval to a submission until all of the required information has been received. In the case of a re-submission, all required changes and/or revisions must be included with the resubmitted documents.
Successful applicants must complete all the necessary requirements for their home institution, which include:
- Fulfilling their institutional Research Ethics Board requirements.
- Observing the progress of contract negotiation between their home institution and the CTN+’s National Directors home institution and promptly responding to their home institution to avoid delays.
- Establishing a grant account per the requirements of their home institution, oversee (if applicable) spending for the study, and provide the CTN+ with financial statements as required.
Before you submit your study to the CTN+, please review the Portfolio Study Submission and Guidance document.
Any questions may be directed to the CTN at 778-990-5372 or by email to submissions@ctnplus.ca.